Correction: PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival

QR Code

Correction: PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival

Saved in:

Bibliographic Details
Main Authors:	Jeremiah L. Oyer, Tayler J. Croom-Perez, Md Faqrul Hasan, Javier A. Rivera-Huertas, Sarah B. Gitto, Joanna M. Mucha, Xiang Zhu, Deborah A. Altomare, Robert Y. Igarashi, Alicja J. Copik
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Immunology
Subjects:	natural killer cell NK cell therapy memory-like NK cells immunotherapy adoptive cell therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1650274/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival
by: Jeremiah L. Oyer, et al.
Published: (2024-04-01)

Phenotypic characteristics of natural killer cells after their generation and activation <i>in vitro</i>
by: E. V. Abakushina, et al.
Published: (2025-03-01)

NK cells expansion <i>in vitro</i> is followed by loss of inhibitory KIR expression
by: N. A. Alekseeva, et al.
Published: (2023-06-01)

Treatment outcome in a patient with triple-negative breast cancer using adoptive immunotherapy
by: E. V. Abakushina, et al.
Published: (2025-07-01)

PECULIARITIES OF NK CELLS DIFFERENTIATION: CD56dim AND CD56bright NK CELLS AT PREGNANCY AND IN NON-PREGNANT STATE
by: V. A. Mikhailova, et al.
Published: (2017-01-01)

Does a natural killer need a CAR?
by: Kangbo Wang, et al.
Published: (2025-06-01)

Natural Killer Cell and Extracellular Vesicle-Based Immunotherapy in Thyroid Cancer: Advances, Challenges, and Future Perspectives
by: Kruthika Prakash, et al.
Published: (2025-07-01)

Flow cytometry analysis of cytotoxic cells in patients with chronic hepatitis C
by: M. S. Selkova
Published: (2014-09-01)

EVALUATION OF MICROVESICLES FORMED BY NATURAL KILLER (NK) CELLS USING FLOW CYTOMETRY
by: V. A. Mikhailova, et al.
Published: (2018-03-01)

Gene and genotype frequencies of immunoglobulin-like natural killer cell receptors in the population of Samara region
by: D. Yu. Klyuchnikov, et al.
Published: (2023-12-01)

Umbilical cord blood as a promising source of NK cells for immunotherapy
by: R. A. Velichinskii, et al.
Published: (2023-06-01)

The role of γδТ- and NK-сells in immune response
by: Ye. G. Churina, et al.
Published: (2010-10-01)

Low-intensity Pulsed Ultrasound Enhances NK Cell Adoptive Therapy by Modulating the Wnt/β-catenin Signaling Pathway
by: Renjie Feng, et al.
Published: (2025-07-01)

Overcoming Immune Barriers in Allogeneic CAR-NK Therapy: From Multiplex Gene Editing to AI-Driven Precision Design
by: Hyunyoung Kim
Published: (2025-06-01)

<i>shp-2</i> gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
by: V. G. Subrakova, et al.
Published: (2020-03-01)

CAR‐NK, a Splendid Strategy for Cancer, Especially for Gynecologic Tumor
by: Yisen Cao, et al.
Published: (2025-06-01)

DIFFERENTIATION OF NK CELLS. A LOOK THROUGH THE PRISM OF TRANSCRIPTION FACTORS AND INTRACELLULAR MESSENGERS
by: V. A. Mikhailova, et al.
Published: (2019-01-01)

Engineered iPSC‐derived natural killer cells: recent innovations in translational innate anti‐cancer immunotherapy
by: Jane Sun, et al.
Published: (2025-01-01)

Lower Number and Percentage of Activated Natural Killer Cells in Colorectal Cancer Patients
by: Amie Vidyani, et al.
Published: (2023-01-01)

Increased proliferative response of highly differentiated CD57<sup>+</sup>NKG2C<sup>+</sup>NK cells expressing NKG2A
by: N. A. Alekseeva, et al.
Published: (2024-09-01)

New strategies for solid tumor immunotherapy based on NK cells
by: I. G. Vorobyova, et al.
Published: (2024-11-01)

Closed-system manufacturing of therapeutic NK cells using automated cell enrichment and concentration processes enables scalable, robust and cost-effective solutions
by: Nina Kok, et al.
Published: (2025-06-01)

Engineered iNKNKG2A KO cells possess HLA-E specific anti-tumor activity
by: QIAO Wenhua, XU Yi, DONG Peng, HE Wei, CHEN Hui, ZHANG Jianmin
Published: (2025-05-01)

MODERN WAYS TO OVERCOME ANTIBIOTIC RESISTANCE AND PROSPECTS FOR THE USE OF NK CELLS AS AGENTS OF ANTIBACTERIAL THERAPY
by: Polina Vladimirovna Grebenkina, et al.
Published: (2019-08-01)

Altered Expression of NK Receptors in Racially/Ethnically Diverse and Risk-of-Relapse Pediatric Acute Lymphoblastic Leukemia Patients
by: Stephen Mathew, et al.
Published: (2025-06-01)

Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR
by: Pui Yeng Lam, et al.
Published: (2025-01-01)

NK cell-based immunotherapy strategies for myeloid leukemia
by: Lin Zhang, et al.
Published: (2025-07-01)

CAR Beyond αβ T Cells: Unleashing NK Cells, Macrophages, and γδ T Lymphocytes Against Solid Tumors
by: Yunjia Xian, et al.
Published: (2025-06-01)

A Type I IFN-Inducing Oncolytic Virus Improves NK Cell-Mediated Killing of Tumor Cells In Vitro Through Multiple Mechanisms
by: Elisabeth M. Shiffer, et al.
Published: (2025-06-01)

EFFECTS OF DEHYDROEPIANDROSTERONE SULFATE UPON PHENOTYPE AND IN VITRO FUNCTIONS OF DENDRITIC CELLS
by: N. V. Seledzova, et al.
Published: (2014-07-01)

Insulin Modulates NK Cell Activity in Liver Fibrosis MASH Patients via the STING Pathway
by: Johnny Amer, et al.
Published: (2025-06-01)

Single-cell RNA-sequencing highlights a curtailed NK cell function in convalescent COVID-19 pregnant women
by: Madhuri S. Salker, et al.
Published: (2025-06-01)

Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis
by: Alexander Biederstädt, et al.
Published: (2025-07-01)

Intravenous immunoglobulins and recombinant granulocyte-colony stimulating factor modulate expression of NK cytotoxic receptors
by: A. A. Davydova, et al.
Published: (2024-11-01)

Natural killer cels in immunotherapy for cancer
by: E. A. Borobova, et al.
Published: (2019-01-01)

IMMUNE DYSFUNCTIONS IN WOMEN WITH INFERTILITY OF UNKNOWN ORIGIN
by: N. A. Khonina, et al.
Published: (2014-07-01)

CD2-targeted nanoparticles encapsulating IL-2 induce tolerogenic Tregs and TGF-β-producing NK cells that stabilize Tregs for long-term therapeutic efficacy in immune-mediated disorders
by: David A. Horwitz, et al.
Published: (2025-07-01)

Anti-HBV treatment partially restores the dysfunction of innate immune cells and unconventional T cells during chronic HBV infection
by: Yiwen Shu, et al.
Published: (2025-07-01)

HETEROGENEITY OF NK AND NKT LYMPHOCYTE POPULATIONS IN HEALTHY DONORS
by: D V. Tabakov, et al.
Published: (2017-08-01)

Preclinical Evaluation of a B7-H3 Targeting Antibody Enhancing NK Cell-Mediated Cytotoxicity for Ovarian Cancer Treatment
by: Hagelstein I, et al.
Published: (2025-07-01)